UNSPSC 51273926: Ephedrine/lidocaine/sodium chloride

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF), which falls under VA Drug Class CN204. This VA Drug Class (CN204) classifies this compound as belonging to the group LOCAL ANESTHETICS, INJECTION.

UNSPSC 51273926 Ephedrine/lidocaine/sodium chloride is a Commodity code, but recent state and local procurement activity under this code shows minimal alignment with the nominal product scope. The three most recent opportunities posted within the past several months—from Seminole County, Florida; the Texas Health and Human Services Commission; and the Minnesota Multistate Cooperative Purchasing Alliance (MMCAP)—center on naloxone procurement, direct-to-manufacturer prescription programs, and generic multi-source pharmaceuticals and OTC products. None of these solicitations specifically target ephedrine/lidocaine/sodium chloride formulations. Issuing bodies include county health departments, state health agencies, and cooperative purchasing consortia spanning multiple jurisdictions. The code shows little recent activity directly tied to the pharmaceutical combination its name implies.

Seminole County, Florida posted IFB 60459723LAS in June 2026 seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries to the Seminole County Community Health Building, with bids due July 26, 2023. Texas HHS issued RFI HHS0017013 in April 2026 to gather vendor capabilities for direct-to-manufacturer prescription programs outside traditional pharmacy benefit manager and wholesaler channels. MMCAP, administered by the Minnesota Department of Administration's Office of State Procurement, released an RFP in January 2026 for generic multi-source pharmaceuticals and OTC products distributed to state and local government facilities in Minnesota and Oregon, with proposals due March 26, 2026 and contract effectiveness July 1, 2026. These solicitations target emergency response drugs, broad pharmaceutical sourcing, and cooperative purchasing arrangements rather than the specific ephedrine/lidocaine/sodium chloride formulations the code nominally covers. Procurement activity is concentrated in Florida, Texas, and the Upper Midwest, though the code's actual current relevance to state and local government purchasing remains unclear.